Figure 3From: Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors Adjusted mean reduction in patient disability reported WHO-DAS II components after 6 months of study in pregabalin and usual care groups. *p < 0.05; **p < 0.01; ***p < 0.001 between groups adjusted by age, sex, and baseline values.Back to article page